about
MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1Human exonuclease 1 functionally complements its yeast homologues in DNA recombination, RNA primer removal, and mutation avoidanceElevated levels of mutation in multiple tissues of mice deficient in the DNA mismatch repair gene Pms2Characterization of the human and mouse WRN 3'-->5' exonucleasePhysical interaction between human RAD52 and RPA is required for homologous recombination in mammalian cellsDNA sequence analysis of spontaneous mutagenesis in Saccharomyces cerevisiaeCritical role of RecN in recombinational DNA repair and survival of Helicobacter pyloriA DNA helicase required for maintenance of the functional mitochondrial genome in Saccharomyces cerevisiae.Molecular basis of genetic instability of triplet repeatsAffinity of mismatch-binding protein MutS for heteroduplexes containing different mismatchesRecombinational repair of DNA damage in Escherichia coli and bacteriophage lambdaHistone deacetylase 10 regulates DNA mismatch repair and may involve the deacetylation of MutS homolog 2.Visualizing protein movement on DNA at the single-molecule level using DNA curtainsHuman MutL homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain.Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice.Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burdenComplex genetic predisposition to cancer in an extended HNPCC family with an ancestral hMLH1 mutation.Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats.Mismatch repair in Escherichia coli cells lacking single-strand exonucleases ExoI, ExoVII, and RecJMismatch repair in Escherichia coli enhances instability of (CTG)n triplet repeats from human hereditary diseasesA naturally occurring hPMS2 mutation can confer a dominant negative mutator phenotype.Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine.Genome-wide hypermutation in a subpopulation of stationary-phase cells underlies recombination-dependent adaptive mutationEvidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene.The msh2 gene of Schizosaccharomyces pombe is involved in mismatch repair, mating-type switching, and meiotic chromosome organization.Opposing roles of the holliday junction processing systems of Escherichia coli in recombination-dependent adaptive mutationA mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma.Genetic variation of the IL-28B promoter affecting gene expression.Role of MED1 (MBD4) Gene in DNA repair and human cancer.Conversion of normal to malignant phenotype: telomere shortening, telomerase activation, and genomic instability during immortalization of human oral keratinocytes.HDAC6 deacetylates and ubiquitinates MSH2 to maintain proper levels of MutSα.Analysis of mutations at the DNA repair genes in acute childhood leukaemia.Human exposure to carcinogenic heterocyclic amines and their mutational fingerprints in experimental animals.Monitoring populations for DNA repair deficiency and for cancer susceptibilityMeasurement of DNA repair deficiency in workers exposed to benzene.Transcription and DNA damage: a link to a kink.Helicase-inactivating mutations as a basis for dominant negative phenotypes.Excision repair in mammalian cells.Mammalian assay for site-specific DNA damage processing using the human H-ras proto-oncogene.Repair of plasmid and genomic DNA in a rad7 delta mutant of yeast.
P2860
Q22009114-07E14A7F-7B89-41C8-92EC-5A18C46953D4Q22009967-A593C56D-86D5-49B0-9A0C-AE1BB51A323EQ22248073-BD63C2EC-33C5-40E4-8077-6FF575F4AF06Q22254412-CDB432EA-7021-416D-AF2B-0C47C3E089DEQ24311394-C8D5178D-FAD9-4ACA-B6A2-184E58D877CEQ24548004-7CBDB67E-B297-4796-A64B-92B863B2BDD5Q24657854-7FA20629-5646-45DD-AB15-FDF86F4D758AQ27930399-C285F618-6F4E-4BC7-8D44-73ABC6A47942Q28277837-1EF724F5-F151-4485-A8EF-2E94FD15BA72Q28359649-E3091A8D-12B8-4BF9-B324-E86144D0EBA5Q29619755-9BE611F5-B14E-444D-AA5E-DE9E526F09CCQ30356611-7D379BFF-B7CA-45BC-BBC1-4E1F10ADA679Q30585002-FE479594-B703-4156-AC38-B587B2C3E238Q31119964-240DF65E-72DD-420D-9980-442D211B5C6BQ33536327-6409DEA0-AC66-45BE-8679-8AE3EB4700B2Q33576170-CC96FB82-8367-4C3F-A63E-8C95BA90C77EQ33677624-15C81B95-E1A8-4188-B660-867FEA88F0ABQ33680162-8DF9DEAB-D177-4B30-B099-84BCA89CD3DDQ33724726-3AF1462A-C9E7-457D-9AAF-7F45DBAC80BEQ33750656-5AA8376A-5E6C-4075-832A-F7A341A133DAQ33772742-7B4BB071-172D-47C5-8FE8-43AE6338A1A3Q33823065-4DC1F6C8-44DF-4EFE-81C8-B694C6F0F1EFQ33886793-AFDE0586-B113-4F6F-AE67-2EA40FE95E66Q33898040-2DA8C48F-DD32-4DB3-8FB4-EE6B176E2A28Q33957081-C1746129-408E-4CCA-9714-52633F662950Q33966750-B8E81C2E-9EC1-4464-8721-827088A22B73Q34021153-EA23C4BB-EFDA-452B-B2B1-ABB0C7630D1CQ34064550-52271AD4-6635-4080-9779-1AD02B6463C7Q34194512-ECAE37CC-9442-46B7-B1F4-F980D0130235Q34249547-11CC537A-26C2-4047-87F0-856619DDAF56Q34301290-68186114-E0DE-4B5A-A768-C42B024B0F97Q34481278-7D74ECBD-297E-45D4-9603-E90DDB86504DQ34636819-00B4BC3E-4757-4D67-A22F-6F950BC8CCEEQ34636883-564B249E-7CFD-4212-8E55-9AF45486C51FQ34636932-13AB2A87-52AB-4DA6-A0A4-324958668596Q34640431-6CADFA07-2CCB-46C3-BC19-E82E39839CC7Q34659857-B4C69CC2-C7E2-43F7-9EA2-647AE0C0D959Q34720551-4FD331A6-5B02-46B6-A05B-8002145C01E9Q34757828-22D48030-CA61-44F8-8CBC-CC4BB02E3425Q34769598-14F3E93F-43DB-4A8E-8F7A-4E159079129B
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Mismatch repair, genetic stability, and cancer.
@en
type
label
Mismatch repair, genetic stability, and cancer.
@en
prefLabel
Mismatch repair, genetic stability, and cancer.
@en
P356
P1433
P1476
Mismatch repair, genetic stability, and cancer.
@en
P2093
P304
P356
10.1126/SCIENCE.7801122
P407
P577
1994-12-01T00:00:00Z